Financial Performance - The company's revenue for Q1 2023 was CNY 864,416,576.59, representing a 211.97% increase compared to CNY 277,087,335.99 in the same period last year[5] - The net loss attributable to shareholders was CNY -133,415,692.70, a decrease of 427.77% from a profit of CNY 40,704,584.19 in the previous year[5] - The basic and diluted earnings per share were both CNY -0.67, down 391.30% from CNY 0.23 in the same period last year[5] - The company reported an operating loss of CNY -132,310,829.67 for Q1 2023, contrasting with an operating profit of CNY 54,553,574.36 in Q1 2022[18] - The net profit for Q1 2023 was -133,530,668.51 CNY, compared to a net profit of 40,631,673.96 CNY in the same period last year, indicating a significant decline[19] - The net profit attributable to the parent company decreased to CNY 325,551,420.71 from CNY 458,967,113.41 year-on-year, a decline of about 29.0%[16] - The company reported a total comprehensive income of -133,530,668.51 CNY for Q1 2023, down from 40,631,673.96 CNY in the previous year[19] Assets and Liabilities - The total assets increased by 11.07% to CNY 5,508,814,838.15 from CNY 4,959,699,000.46 at the end of the previous year[5] - The total liabilities reached CNY 2,575,107,957.59, compared to CNY 1,893,100,918.03 at the beginning of the year, representing an increase of approximately 36.0%[16] - The total number of common shareholders at the end of the reporting period is 31,154[10] - The largest shareholder, Zhao Guanghui, holds 30.21% of shares, amounting to 60,440,448 shares, with 17,000,000 shares pledged[10] Cash Flow - The net cash flow from operating activities was CNY -496,219,499.04, compared to CNY -219,737,412.12 in the same period last year[8] - The cash flow from financing activities increased by 45.17% to CNY 517,597,418.92, mainly due to increased bank borrowings[8] - The total operating cash inflow was 49,940,938.15 CNY, significantly lower than 201,737,160.88 CNY in the previous year[22] - The total operating cash outflow was 546,160,437.19 CNY, compared to 421,474,573.00 CNY in the same period last year[22] - The cash flow from financing activities generated a net inflow of 517,597,418.92 CNY, an increase from 356,547,109.16 CNY in the same period last year[23] - The total cash and cash equivalents at the end of the period stood at 485,617,495.34 CNY, compared to 212,496,351.41 CNY at the end of the previous year[23] Research and Development - Research and development expenses rose by 130.39% to CNY 3,064,512.90, reflecting increased investment in R&D[8] - Research and development expenses for Q1 2023 were CNY 3,064,512.90, up from CNY 1,330,150.21 in the previous year, indicating an increase of approximately 130.0%[18] Investments and Projects - The company plans to invest up to RMB 2 billion in a project to produce 100,000 tons of lithium iron phosphate battery cathode materials, with the project approved by the board on February 24, 2023[12] - An investment agreement was signed for a total investment of approximately RMB 2.5 billion to construct a 200,000-ton integrated phosphoric acid project and a 100,000-ton oxalic acid project[13] Government Support - The company received government subsidies amounting to CNY 106,913.54 during the reporting period[6] Inventory and Current Assets - Current assets totaled CNY 2,940,215,606.17, an increase from CNY 2,664,760,157.98 at the start of the year, marking a growth of about 10.3%[16] - The company’s inventory decreased to CNY 503,224,998.56 from CNY 649,964,341.81, reflecting a reduction of approximately 22.5%[16] Costs and Expenses - The company reported a significant increase in total costs, which rose by 294.85% to CNY 810,635,855.95, primarily due to increased sales volume[8] - Total operating costs for Q1 2023 were CNY 836,300,948.19, compared to CNY 222,627,891.84 in Q1 2022, indicating an increase of about 275.5%[18]

Financial Performance - The company's operating revenue for 2022 reached ¥1,735,732,492.74, representing a 116.14% increase compared to ¥803,047,710.89 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥150,904,006.62, a significant increase of 184.24% from ¥53,090,239.10 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was ¥154,542,211.87, up 200.80% from ¥51,377,073.63 in 2021[21]. - The company's total assets at the end of 2022 amounted to ¥4,959,699,000.46, a 172.99% increase from ¥1,816,825,158.45 at the end of 2021[21]. - The net assets attributable to shareholders increased by 136.53% to ¥2,466,960,348.64 from ¥1,043,001,832.65 in 2021[21]. - The basic earnings per share for 2022 were ¥0.82, an increase of 148.48% compared to ¥0.33 in 2021[21]. - The net cash flow from operating activities was negative at -¥1,478,717,229.64, worsening from -¥51,625,669.02 in 2021[21]. - The weighted average return on net assets for 2022 was 10.52%, up from 6.68% in the previous year[21]. - In 2022, the company achieved total revenue of CNY 1,735,732,492.74, representing a year-on-year growth of 116.14%[78]. - The net profit attributable to shareholders reached CNY 150,904,006.62, a year-on-year increase of 184.24%[78]. - The net assets attributable to shareholders amounted to CNY 2,466,960,348.64, reflecting a year-on-year growth of 136.53%[78]. Dividend and Profit Distribution - The company reported a profit distribution plan, proposing a cash dividend of 1 RMB per 10 shares and a capital reserve increase of 4 shares per 10 shares[4]. - The total number of shares used for the dividend calculation is 200,044,649 shares[4]. - The total distributable profit for the reporting period was CNY 458,967,113.41[183]. - The company plans to distribute a cash dividend of 1 RMB per 10 shares, totaling 20,004,464.90 RMB, based on a total share capital of 200,044,649 shares as of December 31, 2022[184]. - The company plans to increase its share capital by 80,017,860 shares through capital reserves, resulting in a new total share capital of 280,062,509 shares[184]. Research and Development - The company has been focusing on the development of lithium battery cathode materials since 2017, with significant growth in this segment in 2022[20]. - The company plans to increase R&D investment and has acquired advanced research equipment to enhance its innovation capabilities[42]. - The company is actively investing in R&D for high-performance cathode materials, focusing on new materials such as solid-state batteries and sodium-ion batteries[79][80]. - The company has developed new products in lithium iron phosphate batteries, including next-generation safety devices and fast-installation solutions[42]. - The company has applied for a total of 135 patents by the end of 2022, including 42 invention patents and 85 utility model patents[81]. - The company is focusing on innovation-driven development to meet the diverse demands for cathode materials in lithium batteries[48]. - The company is committed to becoming an industry leader by innovating and developing next-generation cathode materials, thereby solidifying its core competitive advantages[104]. Production Capacity and Operations - The company has formed a main business model focusing on lithium battery cathode materials, which accounted for 86.20% of total revenue[21]. - The lithium battery cathode material production capacity reached 125,000 tons for lithium iron phosphate and 5,000 tons for conventional ternary materials by the end of 2022[35]. - The company has a production capacity of 140,000 tons for cathode materials, with 125,000 tons dedicated to lithium iron phosphate, and plans to increase lithium iron phosphate capacity to 300,000 tons by the end of 2023[51]. - The company has established a production capacity of 100,000 tons per year for industrial oxalic acid, refined oxalic acid, and oxalic acid derivatives, maintaining a leading market share in the industry[39]. - The company has initiated trial production for a total of 11.5 million tons of lithium iron phosphate production capacity across three bases: 40,000 tons in Zaozhuang, 25,000 tons in Anqing, and 50,000 tons in Yunnan[83]. - The company is expanding its production lines, with a new lithium iron phosphate production line in Zaozhuang entering trial production in Q3 2022[44]. Market and Strategic Initiatives - The company is positioned to capitalize on the growing demand for lithium battery materials and oxalic acid in various industries, including pharmaceuticals and electronics[36]. - The company is benefiting from national policies supporting the new energy industry, which is expected to drive further growth in the lithium battery sector[32]. - The company is actively expanding its international market presence, having set up an office in South Korea to facilitate technical exchanges and cooperation with clients like LG and SK[134]. - The company plans to focus on the new energy materials industry and aims to become a globally competitive innovative solution provider[131]. - The company is exploring new applications for oxalic acid in emerging electronic industries, which could expand potential demand significantly[38]. - The company is focusing on expanding its market presence and exploring potential mergers and acquisitions to drive growth[39]. Environmental and Social Responsibility - The company has outlined its commitment to environmental and social responsibility in its annual report[4]. - The company has implemented a closed-loop wastewater treatment system, ensuring no wastewater is discharged externally[196]. - The company has replaced coal-fired boilers with gas boilers equipped with low-nitrogen combustion devices to reduce emissions[198]. - The company adheres to multiple environmental protection laws and standards, including the Environmental Protection Law of the People's Republic of China[193]. - The company has established an emergency response plan for environmental incidents, which includes risk assessment and regular emergency drills[200]. Governance and Compliance - The company’s governance structure complies with relevant laws and regulations, ensuring timely and accurate information disclosure and effective investor relations management[150][151]. - The company has established a clear delineation of responsibilities among its governance bodies, ensuring operational independence[154]. - The company has maintained a robust legal framework for asset ownership, with all necessary documentation in place[156]. - The company has demonstrated a commitment to independent decision-making in financial matters, adhering strictly to its articles of association and board resolutions[156]. - The company has complied with tax regulations, with no instances of tax evasion reported[156]. Employee and Management - The total number of employees at the end of the reporting period was 756, with 199 in the parent company and 557 in major subsidiaries[179]. - The company employs a total of 595 production personnel, 23 sales personnel, 69 technical personnel, 13 financial personnel, and 56 administrative personnel[179]. - The company has implemented a training program for employees, focusing on skill enhancement and quality systems[181]. - The company has established a performance assessment mechanism for senior management to ensure shareholder rights are maintained[167]. - The company’s board includes a mix of experienced professionals with backgrounds in management and operations, enhancing its strategic direction[162].

证券代码：002805 证券简称：丰元股份 公告编号：2023-028 （三）会议召开网址：全景•路演（http://rs.p5w.net） （四）本次出席人员：公司董事长、总经理、独立董事、董事会秘书、财务 总监及保荐代表人。 本次业绩说明会以网络互动形式召开，公司将针对 2022 年度的经营成果及 财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内就 投资者普遍关注的问题进行回答。 二、征集问题事项 山东丰元化学股份有限公司 关于举办 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东丰元化学股份有限公司（以下简称"公司"）于 2023 年 3 月 17 日在巨 潮资讯网（http://www.cninfo.com.cn/）披露了《公司 2022 年年度报告》。为 了便于广大投资者进一步了解公司情况，公司拟于 2023 年 3 月 24 日（星期五） 15:00-17:00 在全景网举办公司 2022 年度业绩说明会。现将本次业绩说明会的 相关内容公告如下： 一、业绩说明会安排 （一）会议召开时间：202 ...

Group 1: Company Overview and Performance - Shandong Fengyuan Chemical Co., Ltd. has transitioned to focus on lithium battery cathode materials while maintaining its traditional oxalic acid business. [2] - In the first three quarters of 2022, the company achieved total revenue of ¥1,213,320,721.33, representing a year-on-year growth of 121.89%. [2] - The net profit attributable to shareholders was ¥150,492,997.41, with a significant increase of 288.93% year-on-year, driven by the rapid development of the new energy sector and strong demand from downstream customers. [2] Group 2: Production Capacity and Plans - By the end of 2022, the company's lithium battery cathode material production capacity is expected to reach 140,000 tons, including 125,000 tons of lithium iron phosphate and 15,000 tons of ternary materials. [3] - The company plans to increase its lithium battery cathode material capacity to 315,000 tons by mid-2023, with 300,000 tons of lithium iron phosphate and 15,000 tons of ternary materials. [3] - The production capacity for lithium iron phosphate is distributed across three bases: Zaozhuang (50,000 tons), Anqing (50,000 tons), and Yuxi (200,000 tons). [3] Group 3: Future Outlook and Strategic Initiatives - The company is actively researching sodium-ion and solid-state battery cathode materials, leveraging its technical reserves from the Zhongke Fengyuan High-Energy Lithium Battery Material Research Institute. [3] - The company has a current production capacity of 100,000 tons per year for industrial oxalic acid, refined oxalic acid, and oxalic acid derivatives, and will adjust capacity based on market conditions and customer demand. [4] - The company is progressing with its 1,000-ton clay lithium extraction pilot line, with equipment installation currently underway. [4] Group 4: Market Position and Competition - The company's largest customer is BYD, and further cooperation is expected as new production capacities are released. [4] - The industry is experiencing significant expansion plans, which may lead to structural overcapacity, particularly in mid-to-low-end products. The company aims to provide high-performance lithium battery cathode materials based on core customer needs. [4]

Group 1: Company Overview - The main business of Shandong Fengyuan Chemical Co., Ltd. is the research, production, and sales of oxalic acid series products, including industrial oxalic acid, refined oxalic acid, and oxalic acid derivatives, belonging to the chemical industry [1]. Group 2: Applications of Oxalic Acid - Oxalic acid is an important chemical raw material widely used in pharmaceuticals (for producing raw materials like streptomycin, tetracycline, sulfanilamide, and vitamin B6), rare earth extraction, fine chemicals, textile dyeing, and other fields [2]. Group 3: Production Capacity and Market Share - The company's total production capacity is 95,000 tons/year, with industrial oxalic acid capacity at 85,000 tons/year and refined oxalic acid capacity at 10,000 tons/year. In 2014, China's oxalic acid production was approximately 340,000 tons, with the company's industrial oxalic acid production at 66,800 tons, accounting for about 20% of the market share [2]. Group 4: Market Outlook - The demand for oxalic acid in traditional application areas such as rare earth and pharmaceuticals is relatively stable. However, new uses for vitamin B6 are expected to increase demand, positively impacting the oxalic acid market. Emerging fields like new materials, new energy, and fine chemicals, including lithium battery cathode materials and energy storage, present significant growth opportunities [2].

证券代码：002805 证券简称：丰元股份 山东丰元化学股份有限公司投资者关系活动记录表 编号：2016-001 | --- | --- | --- | |----------------|--------------------------------|-------------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 国金证券股份有限公司原材料研究部基础化工研究员霍堃 | | 人员姓名 | | | | 时间 | 2016-9-19 | | | 地点 | 山东丰元化学股份有限公司会议室 | | | 上市公司接待人 | | 董事会秘书刘艳、证券事务代表王东海 | | 员姓名 | | | | 投资者关系活动 | | 公司董事会秘书与研究员沟通主要内容如下： | | 主要内容介绍 | 1 ...

证券代码：002805 证券简称：丰元股份 山东丰元化学股份有限公司投资者关系活动记录表 编号：2020-001 | --- | --- | |----------------|---------------------------------------------------------------------------------------------| | | | | 投资者关系活动 | □ 特定对象调研 | | 类别 | | | 参与单位名称及 | 方正证券 黄麟 | | 人员姓名 | 中证乾元资本管理有限公司 王传伟、李春建 | | 时间 | 2020 年 11 月 13 日 | | 地点 | 山东省枣庄市台儿庄区经济开发区玉山路山东丰元化学股份 有限公司 | | | | | 上市公司接待人 | 邓燕（董事/总经理）、刘飞（董事/董事会秘书 / 副总经 | | 员姓名 | 理）、张清静（财务总监）、王东海（证券事务代表） | | 投资者关系活动 | | | 主要内容介绍 | 一、丰元股份接待人员陪同调研人员参观公司高镍三元 项目建设现场和磷酸铁锂、三元材料生产车间。 | | | 二、丰元股份接 ...